Molecular detection and genetic identification of Borrelia garinii and Borrelia afzelii from patients presenting with a rare skin manifestation of prurigo pigmentosa in Taiwan  by Chao, Li-Lian et al.
International Journal of Infectious Diseases 17 (2013) e1141–e1147Molecular detection and genetic identiﬁcation of Borrelia garinii and
Borrelia afzelii from patients presenting with a rare skin manifestation
of prurigo pigmentosa in Taiwan
Li-Lian Chao a, Chin-Fang Lu b, Chien-Ming Shih a,c,*
aGraduate Institute of Pathology and Parasitology, Department of Parasitology and Tropical Medicine, National Defense Medical Center, Taipei, Taiwan
bDepartment of Dermatology, Chung Shan Hospital, Taipei, Taiwan
cResearch Center for Biotechnology and Medicine Policy, Taipei, Taiwan
A R T I C L E I N F O
Article history:
Received 11 July 2013
Received in revised form 7 August 2013
Accepted 7 August 2013
Corresponding Editor: Eskild Petersen,
Aarhus, Denmark
Keywords:
Borrelia spirochetes
Prurigo pigmentosa
Lyme disease
Taiwan
S U M M A R Y
Objectives: To determine the genetic identity of Borrelia spirochetes isolated from patients with an
unusual skin lesion of prurigo pigmentosa (PP) in Taiwan. The causative agents responsible for human
borreliosis were clariﬁed.
Methods: Serum samples and skin specimens were collected from 14 patients with suspected PP and ﬁve
controls. Serological testing by Western immunoblot analysis and isolation of Borrelia spirochetes from
skin specimens were used to verify the Borrelia infection. Genetic identities of isolated spirochetes were
determined by analyzing the gene sequences ampliﬁed by PCR assay based on the 5S (rrf)–23S (rrl)
intergenic spacer amplicon gene of Borrelia burgdorferi sensu lato.
Results: Borrelia spirochetes were isolated from skin biopsies of three patients. Serological evidence of
Borrelia infection in these patients was also conﬁrmed by elevated IgG and IgM antibodies against the
major protein antigens of B. burgdorferi. Phylogenetic analysis revealed that these detected spirochetes
are genetically afﬁliated to the genospecies of Borrelia garinii and Borrelia afzelii with high sequence
homology within the genospecies of B. garinii (91.0–98.7%) and B. afzelii (97%).
Conclusions: This study provides the ﬁrst evidence of B. garinii and B. afzelii isolated and identiﬁed in
patients with PP. Whether this unusual skin lesion is a new manifestation of Lyme disease needs to be
studied further.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Lyme disease (LD) is an emerging tick-borne spirochetal
infection that can cause multisystem human illness with varying
degrees of clinical symptoms among infected persons, ranging
from a relatively benign skin lesion to severe arthritic, neurologic,
and cardiac manifestations.1 Based on the clinical manifestations
in patients and the pathogenicity to humans, the causative agent of
Lyme disease can be classiﬁed into four major genospecies: Borrelia
burgdorferi sensu stricto, Borrelia garinii, Borrelia afzelii, and Borrelia
spielmanii.2–4 In previous investigations by our group, Borrelia
spirochetes were isolated from rodent hosts and detected in Ixodes
granulatus ticks in Taiwan.5,6 Although Borrelia spirochetes have
been isolated and identiﬁed in patient skin biopsies,7 isolation
from patients with dermal manifestations of prurigo pigmentosa
(PP) has never been reported.* Corresponding author. Tel.: +886 2 87923152; fax: +886 2 87921821.
E-mail address: cmshih@ndmctsgh.edu.tw (C.-M. Shih).
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http://dx.doi.org/10.1016/j.ijid.2013.08.004PP is a rare dermatosis with an unknown etiology and has been
reported most commonly in Japanese patients since its ﬁrst
description in 1971.8 It is recognized as an inﬂammatory disorder
of the skin characterized clinically by severe pruritic red papules
and erythematous urticarial papules that are symmetrically
localized on the trunk and nape, accompanied by reticulate
pigmentation.8–10 As PP has been reported increasingly in different
races and countries,11–15 investigations on the causative factors
responsible for the etiology and pathogenesis of PP indicate the
correlation with various environmental and biological causes,
including seasonal variation, contact allergens, primary biliary
cirrhosis, Helicobacter pylori infection, atopic disease, and anorexia
nervosa.16–20 The chronic and recurrent nature of PP is quite
similar to the skin manifestations of LD infection,21 and together
with the seasonal prevalence and effective treatment of both of
these disorders with doxycycline, this may imply a possible
correlation between PP and LD infection.
Genomic analysis among Borrelia isolates by sequence
similarity of a speciﬁc target gene has proven useful for the
species identiﬁcation and genomic typing of Borrelia spirochetesses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Photograph of the clinical feature of prurigo pigmentosa on the back of a
25-year-old Taiwanese woman. The lesion presented as intensely pruritic
erythematous red papules and reticular hyperpigmentation.
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The 5S (rrf)–23S (rrl) intergenic spacer amplicon gene is
unique and highly conserved in B. burgdorferi sensu lato.25,26
The diversity of this gene is useful for distinguishing the genetic
heterogeneity among different Borrelia isolates.27–29 Indeed, the
genetic identity of Borrelia spirochetes can be clariﬁed by
analyzing the sequence homology of the 5S (rrf)–23S (rrl)
intergenic spacer amplicon genes of B. burgdorferi sensu lato
isolated from various biological sources,30,31 including skin
specimens from patients.32,33
Thus, the objective of this study was to identify the genospecies
of Borrelia spirochetes isolated from the skin biopsies of patients
characterized with dermal manifestations of PP, by analyzing the
sequence similarity of the PCR-ampliﬁed 5S (rrf)–23S (rrl)
intergenic spacer amplicon genes. In addition, the phylogenetic
relationships of these detected spirochetes were compared with
other Borrelia species documented in GenBank.
2. Materials and methods
2.1. Specimen collection
We conducted an investigation for LD infection among patients
with an unusual clinical manifestation of PP suggestive of LD. A
total of 19 patients were identiﬁed in the dermatology clinic of
Chung Shan Hospital, Taipei; there were 14 cases of suspected PP
and ﬁve healthy control patients. All of these patients had pruritic
red-colored papules with gross reticular pigmentation on the
chest, back, and neck. Among these suspected cases, three native
Taiwanese patients visited the dermal clinic with the chief
complaint of long-lasting skin lesions observed on their body.
These skin lesions had been sustained for 3 months to 4 years with
an unknown etiology. The patients had no history of travel to any
other country during the past 10 years. Based on the clinical
features of intensely pruritic erythematous red papules and
reticular hyperpigmentation (Figure 1), these skin lesions were
diagnosed as cutaneous manifestations of PP. Skin biopsies were
collected for culturing of Borrelia spirochetes. In the meantime,serum specimens from the same patient were subsequently
collected and tested for serological evidence of B. burgdorferi
infection.
2.2. Isolation and puriﬁcation of Borrelia spirochetes
For the isolation of spirochetes, skin biopsy specimens (measur-
ing 2–4 mm in diameter) from the red papular lesions of patients
were cleaned with 75% ethanol solution for 1–2 min and then
washed twice in sterile distilled water. Afterwards, individual skin
specimens were dissected into pieces and inoculated into a culture
tube containing BSK-H medium (B3528; Sigma Co., St. Louis, MO,
USA) supplemented with 6% rabbit serum (R7136; Sigma), as
described previously.34 After incubation at 34 8C in a humidiﬁed
incubator (Sanyo Electric Biomedical Co., Ltd, Osaka, Japan) with 5%
CO2, skin cultures were examined weekly for 8 weeks for evidence of
spirochetes by dark-ﬁeld microscopy (BX-60, Olympus Co., Tokyo,
Japan). For the puriﬁcation of cultured spirochetes, spirochete-
positive cultures with other contamination were transferred to new
culture tubes by serial dilution and were further ﬁltered with a 0.45-
mm pore size syringe ﬁlter (Sartorius, Gottingen, Germany), as
described previously.5,34 In addition, all the spirochete-positive
cultures were also stored in a deep freezer (80 8C) until further
investigation.
2.3. Serological analysis for LD infection
Serodiagnosis for LD infection was performed with a screening
test by indirect immunoﬂuorescence assay (IFA) followed by
Western immunoblot (WB) analysis using paired serum samples
collected from the same patient, as recommended by the US
Centers for Disease Control and Prevention (CDC).35 Brieﬂy, ﬁve
strains of Borrelia spirochetes (strains B31, TWKM1, TWKM5, K48,
and VS461) from pure cultures were used as antigens for both IFA
and WB analysis, as described previously.5,34 Electrophoresed
Borrelia proteins were transferred from the sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gels to
nitrocellulose blotting membranes using a semi-dry electroblot-
ter (PhastTransfer electrode cassette; Pharmacia Biotech). The
transferred membranes were blocked for 2 h with 3% gelatin in
Tris-buffered saline (TBS, pH 7.5) containing 20 mM Tris and
500 mM NaCl, and then incubated for 2 h at room temperature in a
1:20 dilution of serum specimens. After being washed with buffer
solution, the membranes were further immersed for 2 h in
alkaline phosphatase (AP)-conjugated goat anti-human IgG
(catalog No. 109-055-008; Jackson ImmunoResearch Inc., USA)
and IgM (catalog No. 109-055-043; Jackson ImmunoResearch
Inc.) diluted 1:5000 with 0.05% Tween 20 in TBS (T-TBS), as
described previously.5,34 The reacted membranes were then
washed twice with T-TBS, and a substrate solution (10 ml of
nitroblue tetrazolium, catalog No. B-5655; Sigma) was added to
develop the color for 1 min; the reacted membranes were then
washed with distilled water and air-dried for analysis of
spirochetal protein bands.
2.4. DNA extraction from skin cultures
Total genomic DNA was extracted from individual spirochete-
positive cultures with the DNeasy Tissue Kit (catalog No. 69506;
Qiagen, Taipei, Taiwan) and used as a template for PCR
ampliﬁcation. Brieﬂy, individual positive-culture medium together
with dissected skin was placed in a microcentrifuge tube and
centrifuged for 20 min at 12 000  g to pellet the spirochetes. After
removing the supernatant, the microcentrifuge tube was ﬁlled
with 180 ml lysing buffer solution and was further processed with
the DNeasy Tissue Kit, as per the manufacturer’s instructions. After
L.-L. Chao et al. / International Journal of Infectious Diseases 17 (2013) e1141–e1147 e1143ﬁltration, the eluate was collected and the DNA concentration was
determined spectrophotometrically with a DNA calculator (Gene-
Quant II; Pharmacia Biotech, Uppsala, Sweden).
2.5. DNA ampliﬁcation by Borrelia-speciﬁc PCR
A nested PCR was performed with primers designed to amplify
the variable spacer region between two conserved duplicate
structures. A primer set corresponding to the 30 end of the 5S rRNA
(rrf) (50-CGACCTTCTTCGCCTTAAAGC-30) and the 50 end of the 23S
rRNA (rrl) (50-TAAGCTGACTAATACTAATTACCC-30) was designed
and applied for the primary ampliﬁcation, as described previous-
ly.26 In the nested PCR, a primer set of primer 1 (50-
CTGCGAGTTCGCGGGAGA-30) and primer 2 (50-TCCTAGGCATT-
CACCATA-30) was used and expected to yield a 210–260-bp
fragment depending on the Borrelia strain, as described previ-
ously.36 All PCR reagents and Taq polymerase were obtained and
used as recommended by the manufacturer (Takara Shuzo Co., Ltd,
Japan). Brieﬂy, a total of 0.2 mmol of the appropriate primer set
and various amounts of template DNA were used in each 50-ml
reaction mixture. PCR ampliﬁcation was performed with a Perkin-
Elmer Cetus Thermocycler (GeneAmp System 9700; Taipei,
Taiwan), and the primary ampliﬁcation included 2 min denatur-
ation at 96 8C followed by 30 cycles of the following conditions:
denaturation at 94 8C for 30 s, annealing at 55 8C for 30 s, and
extension at 72 8C for 40 s. Nested ampliﬁcation was performed
under the same conditions except the annealing at 59 8C for 30 s.
Afterwards, PCR-ampliﬁed DNA products were electrophoresed
on 2% agarose gels in Tris–borate–EDTA (TBE) buffer and were
visualized under ultraviolet (UV) light after staining with
ethidium bromide. A DNA ladder (1-kb plus, catalog No. 10787-
018; Invitrogen, Taipei, Taiwan) was used as the standard markerTable 1
Genospecies and strains of Borrelia spirochetes used for phylogenetic analysis in this s
Genospecies and strain Origin of Borrelia strain 
Biological 
Taiwan strain
Bg-PP-TW1 Human skin 
Bg-PP-TW2 Human skin 
Ba-PP-TW1 Human skin 
B. burgdorferi sensu stricto
B31 Ixodes scapularis 
IP1 Human CSF 
TWKM5 Rattus norvegicus 
Bbss-MP-TW Human skin 
B. garinii
20047 Ixodes ricinus 
NP81 Ixodes persulcatus 
Mp-TW1 Human skin 
B. afzelii
VS461 Ixodes ricinus 
BO23 Human skin 
Ba-MP-TW Human skin 
B. bissettii
DN127 Ixodes paciﬁcus 
CA376 Neotoma fuscipes 
B. spielmanii
A14S Human skin 
PC-Eq17N5 Ixodes ricinus 
B. valaisiana
VS116 Ixodes ricinus 
CKA2a Apodemus agrarius 
B. sinica
CMN3 Niviventer sp 
CWO1 Ixodes ovatus 
CSF, cerebral spinal ﬂuid.
a GenBank accession numbers JX649205 to JX649207 were submitted by this studyfor comparison. A negative control of distilled water was included
in parallel with each ampliﬁcation.
2.6. Sequence alignment and phylogenetic analysis
After puriﬁcation (QIAquick PCR Puriﬁcation Kit, catalog No.
28104), sequencing reactions were performed by dye-deoxy
terminator reaction method using the Big Dye Terminator Cycle
Sequencing Kit in an ABI Prism 377–96 DNA Sequencer (Applied
Biosystems, Foster City, CA, USA). The resulting sequences were
initially aligned with the CLUSTAL W software37 and further
analyzed by comparing with other Borrelia sequences available in
GenBank. Neighbor-joining (NJ) compared with maximum
parsimony (MP) methods were used to estimate the phylogeny
of the entire alignment using MEGA 4.0 software package.38 A
similarity matrix was also constructed using the DNASTAR
program (Lasergene, version 8.0). All phylogenetic trees were
constructed and performed with 1000 bootstrap replications to
evaluate the reliability of the constructions, as described
previously.39
2.7. Nucleotide sequence accession numbers
The nucleotide sequences of PCR-ampliﬁed 5S (rrf)–23S (rrl)
intergenic spacer amplicon genes from Borrelia spirochetes
determined in this study have been registered and assigned the
following GenBank accession numbers: JX649205 (strain Bg-PP-
TW1), JX649206 (strain Bg-PP-TW2), and JX649207 (strain Ba-PP-
TW1). In the phylogenetic analysis, the nucleotide sequences of the
5S (rrf)–23S (rrl) intergenic spacer amplicon gene from various
Borrelia species were included for comparison; their GenBank
accession numbers are shown in Table 1.tudy
5S (rrf)–23S (rrl) gene accession numbera
Geographic
Taiwan JX649205
Taiwan JX649206
Taiwan JX649207
USA L30127
France AF090977
Taiwan AY032908
Taiwan GQ499848
France L30119
Japan D84406
Taiwan FJ686175
Switzerland L30135
Sweden Z77174
Taiwan GQ499849
USA L30126
USA AY177634
Netherlands U76616
France DQ133526
Switzerland L30134
China AB022124
China AB022131
China AB022130
.
Figure 2. Ampliﬁcation of Borrelia DNA from skin cultures of patients by nested PCR
assay based on the 5S (rrf)–23S (rrl) rRNA gene. Lanes: M, molecular marker; 1 to 14,
patients with prurigo pigmentosa-like skin lesions; N, negative control.
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3.1. Culture of spirochetes
Cultures of skin biopsies from patients with skin lesions of PP
demonstrated B. burgdorferi-like spirochetes in the skin cultures of
only three patients, at 10 to 20 days after initial inoculation
(Table 2). Puriﬁcation of cultivable spirochetes was performed by
serial dilution of ﬁltrated cultures, and pure isolates of B.
burgdorferi-like spirochetes were also observed in culture medium
at 3 to 7 days after ﬁltrated passage. To obtain sufﬁcient quantities
of cultivable spirochetes, all positive cultures were allowed to
grow in BSK-H medium for another 2 weeks.
3.2. Serodiagnosis of LD infection
Serodiagnosis of LD infection in our patients was made with
the IFA test, with a positive reactivity (>1:40) against Borrelia
spirochetes, and conﬁrmed by WB analysis, with the presence of
several major antigenic proteins that are known to be correlated
with B. burgdorferi infection. As shown in Table 2, WB analysis
using paired serum samples collected from the same patient
revealed elevated IgG and IgM antibodies against the major
protein antigens of B. burgdorferi. In two patients, signiﬁcant IgG
reactivity with the 41-, 58-, 66-, and 72-kDa protein antigens of B.
burgdorferi was observed, with signiﬁcant IgM reactivity against
the 41-, 66-, 72-, and 76-kDa protein bands of B. burgdorferi
(Table 2). Another patient with long-lasting PP for 4 years showed
signiﬁcant IgG and IgM reactivities with the 41-, 66-, and 72-kDa
protein antigens of B. burgdorferi. In contrast, all healthy control
patients showed no seroreactivity against the major protein
antigens of B. burgdorferi and only two out of 11 culture-negative
patients showed weak seroreactivity with the 41-kDa protein
antigen of B. burgdorferi.
3.3. DNA ampliﬁcation and genetic analysis
To clarify the genetic identity of Borrelia spirochetes, we
employed a nested PCR assay to achieve a high sensitivity and
speciﬁcity for Borrelia detection. In this study, nested PCR assays
revealed ampliﬁed DNA fragments of approximately 260 bp from
skin cultures of infected patients (Figure 2). Based on comparison
of the 5S–23S intergenic spacer amplicon gene sequences among
21 Borrelia spirochetes, the genetic identity of strains Bg-PP-TW1
and Bg-PP-TW2 isolated from patient skin was veriﬁed with a high
sequence homology within the genospecies of B. garinii (91.0–
98.7%), and the strain Ba-PP-TW1 was veriﬁed with a high
sequence homology within the genospecies of B. afzelii (97%)
(Table 3). Phylogenetic analysis also revealed that these detected
spirochetes represent two monophyletic groups closely afﬁliated
to the genospecies of B. garinii and B. afzelii, and constitute two
separate clades distinguished clearly from other Borrelia genos-
pecies by both neighbor-joining and maximum parsimony
methods (Figure 3).Table 2
Clinical features and laboratory analysis of Borrelia burgdorferi infection in three patien
Patient sex/age (years) Clinical features Reactivity bands by Weste
Female/25 PP skin lesion (3 months) IgG: 41, 58, 66, 72 kDa
IgM: 41, 66, 72, 76 kDa
Male/33 PP skin lesion (2 years) IgG: 41, 58, 66, 72 kDa
IgM: 41, 66, 72, 76 kDa
Male/63 PP skin lesion (4 years) IgG: 41, 66, 72 kDa
IgM: 41, 66, 72 kDa
PP, prurigo pigmentosa.
a Genospecies identiﬁcation based on 5S (rrf)–23S (rrl) intergenic spacer amplicon g4. Discussion
Our report provides the ﬁrst convincing evidence of B. garinii
and B. afzelii spirochetes isolated from patients presenting with
rare PP skin lesions in Taiwan. In our previous investigations, LD
spirochetes were isolated from rodent hosts captured at various
locations in Taiwan5, and the Ixodes granulatus tick was recognized
as the principle vector tick for enzootic transmission of Borrelia
spirochetes in Taiwan.40 In addition to the discovery of human
borreliosis in Taiwan,7,41–43 the isolation and identiﬁcation of the
causative agents responsible for LD infection in patients presenting
with various clinical manifestations are required to verify the
genetic polymorphism of Borrelia spirochetes. Indeed, the results
from the present study conﬁrm the heterogeneity of Borrelia
spirochetes existing in the skin biopsies of humans and demon-
strate that these detected spirochetes are genetically afﬁliated to
the genospecies of B. garinii and B. afzelii. Further study focusing on
the detection of Borrelia spirochetes among patients with varying
degrees of clinical symptoms would help to elucidate the
pathogenesis of Borrelia spirochetes in humans in Taiwan.
Although all these PP patients were characterized by pruritic
red-colored papules with gross reticular pigmentation on the
trunk, the etiological role of Borrelia spirochetes in the pathogene-
sis of PP remains unclear. It is interesting that the skin lesions of PP
share some clinical and histopathological characteristics with
acrodermatitis chronica atrophicans (ACA), which is a late
cutaneous manifestation associated with LD infection.44,45 Indeed,
late LD may develop among some patients months to a few years
after a tick-transmitted infection, and ACA appears to be the most
common manifestation of late LD in Europe.45,46 The possible
association of Borrelia spirochetes in the pathogenesis of ACA has
been assumed by the isolation of Borrelia spirochetes from patients
with ACA.47 In the present study, Borrelia spirochetes were isolated
from skin specimens of patients with PP skin lesions and Borrelia
species was also veriﬁed by a nested PCR targeting the 5S–23Sts
rn immunoblot test Borrelia culture detected Borrelia species identiﬁeda
Positive at 10 days B. afzelii
Positive at 20 days B. garinii
Positive at 20 days B. garinii
ene of B. burgdorferi sensu lato.
Table 3
Sequence similarity between 5S (rrf)–23S (rrl) gene sequences from Taiwan strains isolated from patients with prurigo pigmentosa and strains of other Borrelia genospecies
Genospecies and straina B31 Bbss-MP-TW 20047 Mp-TW1 Bg-PP-TW1 Bg-PP-TW2 VS461 Ba-MP-TW Ba-PP-TW1 DN127 A14S VS116 CMN3
B31 - 97.0 91.4 90.6 84.5 88.4 85.8 85.8 83.3 91.8 77.3 89.3 80.3
Bbss-MP-TW - 91.0 90.1 84.1 88.0 86.3 86.3 83.7 89.7 76.8 88.4 79.8
20047 - 98.7 91.4 94.8 89.3 89.3 86.7 89.3 78.5 91.0 80.3
Mp-TW1 - 91.0 95.3 88.8 88.8 86.3 88.4 77.7 90.6 79.4
Bg-PP-TW1 - 91.0 83.3 83.3 82.0 82.0 72.1 84.1 73.4
Bg-PP-TW2 - 87.6 87.6 88.8 85.8 76.0 88.4 77.3
VS461 - 100.0 97.0 85.0 74.7 88.0 81.1
Ba-MP-TW - 97.0 85.0 74.7 88.0 81.1
Ba-PP-TW1 - 82.4 72.5 85.4 78.5
DN127 - 76.8 89.3 79.4
A14S - 79.0 83.3
VS116 - 81.5
CMN3 -
a Strains: B31 and Bbss-MP-TW, B. burgdorferi sensu stricto; 20047 and Mp-TW1, B. garinii; VS461 and Ba-MP-TW, B. afzelii; DN127, B. bissettii; A14S, B. spielmanii; VS116, B.
valaisiana; CMN3, B. sinica.
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results suggest that Borrelia spirochetes may play a role in the
pathogenesis of PP in Taiwan.
Because the recurrent urticarial- or eczema-like skin lesions on
the trunk were observed in the majority of patients with suspected
PP. It is possible that seasonal variation and contact allergens may
have contributed to the cause of PP in our Borrelia culture-negative
patients. Indeed, previous investigations have also indicated that
the causative factors responsible for the etiology and pathogenesis
of PP include seasonal variation, contact allergens, mechanical
stimuli (friction from clothing), primary biliary cirrhosis, Helico-
bacter pylori infection, atopic disease, and anorexia nervosa.16–20
Thus, it is highly recommended that PP is differentiated from other
common dermatological diseases in patients with recurrent
urticarial- or eczema-like skin lesions in the clinical diagnosis.B. garinii Mp-TW1 (FJ68617 5)
Bg-PP-TW2
Bg-PP -TW1
B. ga rinii 2004 7(L3011 9)
B. ga rinii NP81 (D8440 6)
Ba-PP -TW1
B. afzeli i VS461 (L3013 5)
B. afzeli i BO23 (Z77174)
B. afzeli i Ba-MP-TW (GQ499849 )
B. bissettii DN 127 (L30126)
B. bissettii CA376 (AY177 634)
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B. burgdo rferi B31 (L30127 )
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Figure 3. Phylogenetic relationships based on a comparison of the 5S (rrf)–23S (rrl) rRNA g
PP-TW1) isolated from human skin in Taiwan and 18 other strains of Borrelia spirochete
parsimony (B) methods using 1000 bootstrap replicates. Numbers at the nodes indicate
proportional to the estimated sequence divergence.The existence of two tandem duplicated copies of the rrl (23S)
and rrf (5S) genes in LD spirochetes is unique and has not been
found in other members of the genus Borrelia or in other
eubacteria.25,26 Taking advantage of this unique genomic charac-
teristic, the genetic identity of Borrelia spirochetes can be
distinguished by their differential reactivities with genospecies-
speciﬁc PCR primers targeting the 5S (rrf)–23S (rrl) intergenic
spacer amplicon gene. Indeed, genetic heterogeneity can be further
classiﬁed among Borrelia isolates that have previously been
identiﬁed as the same genospecies, or atypical strains of Borrelia
spirochetes.28,29 Results from the present study also clarify that the
genetic identity of Borrelia spirochetes isolated from skin biopsy
specimens of Taiwanese patients is highly homogeneous within
the genospecies of B. garinii and B. afzelii, and is clearly
distinguished from other genospecies of Borrelia spirochetesB
B. afzelii VS46 1 (L30135 )
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ene sequences between three Borrelia spirochetes (Bg-PP-TW1, Bg-PP-TW2, and Ba-
s. The trees were constructed and analyzed by neighbor-joining (A) and maximum
 the percentages of reliability of each branch of the tree. Branch lengths are drawn
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based on the rrf–rrl genes to analyze the Borrelia spirochetes
detected in various vector ticks may help to clarify the natural
transmission cycle of Borrelia spirochetes in Taiwan.
A spirochetal infection can be veriﬁed by the presence of
cultivable spirochetes in skin cultures. Although the in vitro
isolation of Borrelia spirochetes from the infected skin is
insensitive, culture of Borrelia spirochetes undoubtedly provides
the best conﬁrmation of active infection. Indeed, culture of skin
biopsy specimens gives the highest success rates for clinical
samples,48,49 and the successful recovery of Borrelia spirochetes
has been reported from patients characterized with late cutaneous
manifestations more than 10 years after the onset of the skin
lesions.47 Results from the present cases also showed the positive
culture of Borrelia spirochetes from skin specimens of infected
patients with long-lasting skin lesions at 3 months to 4 years after
onset. Indeed, B. burgdorferi-like spirochetes were observed in skin
cultures at 10 to 20 days after initial inoculation (Table 2). These
observations reveal the feasibility of culturing Borrelia spirochetes
from skin specimens of patients with a chronic skin lesion of PP
presenting as a late cutaneous manifestation of LD.
Regardless of the two-tier testing approach recommended by
the CDC,35 a positive diagnosis as suggested by the European Union
Concerted Action on Lyme Borreliosis (EUCALB) requires only two
seroreactive bands among 10 major Borrelia protein antigens for
IgG WB, and only one seroreactive band among three major
Borrelia protein antigens (17, 23, and 39 kDa) or a strong 41-kDa
band for IgM WB.50 Thus, our patients meet the deﬁned
requirement for positive seroconversion associated with human
LD according to the diagnostic criteria recommended by EUCALB.
The differential WB banding in infected patients may depend on
the duration of infection and the manifestations of LD. In early LD,
IgG and IgM antibody reactivities to the OspC (21–23 kDa) and
ﬂagellar (41 kDa) antigens are frequently observed.51–53 However,
a previous study on the frequency of WB reactivity to speciﬁc
Borrelia protein antigens has also revealed that seroreactivity of
IgG and IgM antibodies against the higher molecular weight mass
bands (41 kDa and above) is most frequently detected in infected
patients.54 Results from the present cases also revealed signiﬁcant
seroreactivities of IgG and IgM antibodies against the higher
molecular weight mass bands of Borrelia protein antigens
(Table 2). Moreover, the present cases also showed the persistence
of elevated anti-B. burgdorferi IgG and IgM antibody titers during
the prolonged infection course. These results demonstrate the
signiﬁcance of persistent seroreactivity of individual patients
against Borrelia protein antigens. Further investigations focused on
the variant seroreactivities of WB banding in culture-positive
patients classiﬁed by various clinical manifestations would be
beneﬁcial to the establishment of standardized criteria for the
serodiagnosis of LD infection in Taiwan.
In conclusion, our ﬁndings provide the ﬁrst convincing evidence
regarding the identiﬁcation of B. garinii and B. afzelii from patients
presenting with PP, an unusual dermal manifestation of LD in
Taiwan. Further investigations focusing on the detection of
Borrelia spirochetes among patients with various clinical mani-
festations may enhance our understanding of the signiﬁcance of
genetic diversity of Borrelia spirochetes in relation to the
pathogenicity of LD infection in Taiwan.
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